Discover 1,106 paid clinical trials in Salt Lake City, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
There are a wide variety of studies currently listed in Salt Lake City, focusing on conditions such as autism, celiac disease, and osteoporosis. The city's leading medical research institutions are actively recruiting participants, providing access to cutting-edge treatments and therapies for both healthy volunteers interested in paid clinical trials and individuals in need of studies for specific health conditions.
Filter
2
Filter results
Results: 1,106
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Salt Lake City UT, Henderson NV, Aurora CO, Phoenix AZ,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase 3, Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Salt Lake City UT, Los Angeles CA, La Jolla CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05896839
Phase 1, Phase 2, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Salt Lake City UT, Henderson NV, Denver CO, Goodyear AZ,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Salt Lake City UT, Las Vegas NV, Englewood CO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer
for
Breast Cancer
Location: Salt Lake City UT, Houston TX
Sponsor: Vestan, Inc.
Sex: All
Age: 18+
Code: NCT02294565
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
for
Locally Advanced Solid Tumor
Location: Salt Lake City UT, Grand Junction CO, Palo Alto CA,
Sponsor: Tango Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05732831
Phase 1, Phase 2, Recruiting
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
for
Recurrent Glioblastoma
Location: Salt Lake City UT, San Francisco CA, Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06069726
Phase 2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Salt Lake City UT, Aurora CO, Phoenix AZ, Scottsdale AZ,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase 3, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Location: Salt Lake City UT, Billings MT, Long Beach CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06881784
Phase 3, Recruiting
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
for
Non-small Cell Lung Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 0+
Code: NCT06934343
Recruiting
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Salt Lake City UT, Scottsdale AZ, Fairfax VA,
Sponsor: Peel Therapeutics Inc
Sex: All
Age: 18+
Code: NCT05329103
Phase 1, Recruiting
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
for
Solid Tumors, ER+ Breast Cancer,
Location: Salt Lake City UT, Dallas TX, St Louis MO, Detroit MI
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT05490472
Phase 1, Phase 2, Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Salt Lake City UT, Portland OR, Westwood KS, Houston TX,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT05875168
Phase 1, Phase 2, Recruiting
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
for
Castration-resistant Prostate Cancer
Location: Salt Lake City UT, Duarte CA, Los Angeles CA
Sponsor: Edwin Posadas, MD
Sex: Male
Age: 18+
Code: NCT05534646
Phase 2, Recruiting
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
for
Glioblastoma, IDH-wildtype, Glioblastoma,
Location: Salt Lake City UT, Houston TX, Detroit MI, Cleveland OH,
Sponsor: Orbus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05879367
Phase 1, Recruiting
Reach Through Equitable Implementation in Utah
for
Tobacco Use Cessation, Tobacco Use, Tobacco Smoking,
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT06881069
Recruiting
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
for
Solid Tumor
Location: Salt Lake City UT, Duarte CA, Los Angeles CA, Irvine CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT04939610
Phase 1, Phase 2, Recruiting
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma